Cargando…
T cells armed with the C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours
The efficacy of adoptive cell therapy for solid tumours is hampered by the poor accumulation of the transferred T cells in tumour tissue. Here, we show that the forced expression of the C-X-C chemokine receptor type 6 (CXCR6, whose ligand is highly expressed by human and murine pancreatic cancer cel...
Ejemplares similares
-
High-affinity CD16-polymorphism and Fc-engineered antibodies enable activity of CD16-chimeric antigen receptor-modified T cells for cancer therapy
por: Rataj, Felicitas, et al.
Publicado: (2018) -
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2019) -
Impact of the selective A2(A)R and A2(B)R dual antagonist AB928/etrumadenant on CAR T cell function
por: Seifert, Matthias, et al.
Publicado: (2022) -
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma
por: Märkl, Florian, et al.
Publicado: (2023) -
Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors
por: Cadilha, Bruno L., et al.
Publicado: (2021)